{"entity":{"type":"insider","cik":"0001405235","url":"/insider/0001405235","json_url":"/insider/0001405235.json","name":"Wegman Mark N","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2018-08-23","last":"2019-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Wegman Mark N","source":"filing","n_filings":5,"first_seen":"2018-08-23","last_seen":"2019-05-28"}],"transactions":[{"id":8726442,"accession":"0001062993-19-002432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-19-002432","line_url":"/filing/0001062993-19-002432#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7800.0,"shares_display":"7,800","price_per_share":61.09,"price_display":"61.09","price_state":"stated","total_value":476502.0,"total_display":"476,502.00","total_whole":"476,502","shares_owned_after":65272.0,"shares_owned_after_display":"65,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-24","filed_date":"2019-05-28","scope":"insider"},{"id":7860096,"accession":"0001062993-19-002394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-19-002394","line_url":"/filing/0001062993-19-002394#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":63.7,"price_display":"63.70","price_state":"stated","total_value":76440.0,"total_display":"76,440.00","total_whole":"76,440","shares_owned_after":73072.0,"shares_owned_after_display":"73,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-23","scope":"insider"},{"id":7942736,"accession":"0001062993-19-002372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-19-002372","line_url":"/filing/0001062993-19-002372#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":64.0394,"price_display":"64.04","price_state":"stated","total_value":384236.4,"total_display":"384,236.40","total_whole":"384,236","shares_owned_after":74272.0,"shares_owned_after_display":"74,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider"},{"id":6571359,"accession":"0001062993-18-003711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-18-003711","line_url":"/filing/0001062993-18-003711#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":58.655,"price_display":"58.66","price_state":"stated","total_value":58655.0,"total_display":"58,655.00","total_whole":"58,655","shares_owned_after":65272.0,"shares_owned_after_display":"65,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-11","filed_date":"2018-09-11","scope":"insider"},{"id":6571356,"accession":"0001062993-18-003711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-18-003711","line_url":"/filing/0001062993-18-003711#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":57.3102,"price_display":"57.31","price_state":"stated","total_value":315206.1,"total_display":"315,206.10","total_whole":"315,206","shares_owned_after":66272.0,"shares_owned_after_display":"66,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-10","filed_date":"2018-09-11","scope":"insider"},{"id":6493398,"accession":"0001062993-18-003527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-18-003527","line_url":"/filing/0001062993-18-003527#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4698.0,"shares_display":"4,698","price_per_share":52.5604,"price_display":"52.56","price_state":"stated","total_value":246928.7592,"total_display":"246,928.76","total_whole":"246,929","shares_owned_after":71772.0,"shares_owned_after_display":"71,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-23","scope":"insider"},{"id":6493396,"accession":"0001062993-18-003527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-18-003527","line_url":"/filing/0001062993-18-003527#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405235","owner_name":"Wegman Mark N","owner_display_name":"Wegman Mark N","owner_url":"/insider/0001405235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3802.0,"shares_display":"3,802","price_per_share":52.7073,"price_display":"52.71","price_state":"stated","total_value":200393.1546,"total_display":"200,393.15","total_whole":"200,393","shares_owned_after":76470.0,"shares_owned_after_display":"76,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-22","filed_date":"2018-08-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875622","name":"BIOSPECIFICS TECHNOLOGIES CORP","url":"/issuer/0000875622","role":"Director","n_filings":5,"first_seen":"2018-08-23","last_seen":"2019-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405235","retrieved_at":"2026-08-25T17:47:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}